Search Orphan Drug Designations and Approvals
-
Generic Name: | Sitaxentan (also known as sitaxsentan) |
---|---|
Date Designated: | 01/11/2021 |
Orphan Designation: | Treatment of Systemic Sclerosis |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Timber Pharmaceuticals, Inc. 50 Tice Boulevard, Suite A26 Woodcliff Lake, New Jersey 07677 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-